-
EP2985039
European procedure
Extract from the Register of European Patents
EP About this file: EP2985039
| EP2985039 - TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 07.06.2019 Database last updated on 15.06.2024 | |
| Former | The patent has been granted Status updated on 29.06.2018 | ||
| Former | Grant of patent is intended Status updated on 14.02.2018 | ||
| Former | Examination is in progress Status updated on 20.03.2017 | Most recent event Tooltip | 07.06.2019 | No opposition filed within time limit | published on 10.07.2019 [2019/28] | Applicant(s) | For all designated states ReVance Therapeutics, Inc. 7555 Gateway Blvd. Newark, CA 94560 / US | [2016/07] | Inventor(s) | 01 /
Dake, Michael D. 665 Gerona Road Stanford, CA 94305 / US | 02 /
Waugh, Jacob M. 555 Bryant St., 817 Palo Alto, CA 94301 / US | [2018/24] |
| Former [2016/17] | 01 /
Dake, Michael D. 665 Gerona Road Stanford, CA 94305 / US | ||
| 02 /
Waugh, Jacob M. 555 Bryant St., 817 palo Alto, CA 94301 / US | |||
| Former [2016/07] | 01 /
Dake, Michael D. 665 Gerona Road Stanford, CA 94305 / US | ||
| 02 /
Waugh, Jacob M. 425 First Street No. 1801 San Francisco, CA 94105 / US | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2018/31] | J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | ||
| Former [2016/07] | Wright, Simon Mark J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 15185714.1 | 03.03.2005 | [2016/07] | Priority number, date | US20040550015P | 03.03.2004 Original published format: US 550015 P | [2016/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2985039 | Date: | 17.02.2016 | Language: | EN | [2016/07] | Type: | B1 Patent specification | No.: | EP2985039 | Date: | 01.08.2018 | Language: | EN | [2018/31] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 14.01.2016 | Classification | IPC: | A61K51/00, A61K39/42, A61K39/40, A61K47/18, A61K47/42 | [2016/07] | CPC: |
A61Q19/08 (EP,IL,KR,US);
A61K39/42 (KR);
A61K47/34 (EP,IL,KR,US);
A61K47/42 (EP,IL,KR,US);
A61K47/50 (KR);
A61K47/645 (EP,US);
A61K8/64 (EP,IL,KR,US);
A61K9/0014 (EP,IL,US);
A61K9/28 (KR);
A61P13/00 (EP);
A61P15/14 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P17/14 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/06 (EP);
A61P25/08 (EP);
A61P25/16 (EP);
A61P27/16 (EP);
A61P29/00 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
A61P3/14 (EP);
A61P35/00 (EP);
A61P37/04 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2016/39] |
| Former [2016/07] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | TOPISCHE ANWENDUNG UND TRANSDERMALE ABGABE VON BOTULINUMTOXINEN | [2016/07] | English: | TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS | [2016/07] | French: | APPLICATION TOPIQUE ET D'ADMINISTRATION TRANSDERMIQUE DE TOXINES BOTULINIQUES | [2016/07] | Examination procedure | 17.08.2016 | Examination requested [2016/39] | 23.09.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 02.12.2016 | Amendment by applicant (claims and/or description) | 17.03.2017 | Despatch of a communication from the examining division (Time limit: M06) | 27.09.2017 | Reply to a communication from the examining division | 15.02.2018 | Communication of intention to grant the patent | 22.06.2018 | Fee for grant paid | 22.06.2018 | Fee for publishing/printing paid | 22.06.2018 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP05731866.9 / EP1729821 | EP13173674.6 / EP2656859 | Opposition(s) | 03.05.2019 | No opposition filed within time limit [2019/28] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 02.12.2016 | Request for further processing filed | 02.12.2016 | Full payment received (date of receipt of payment) Request granted | 14.12.2016 | Decision despatched | Fees paid | Renewal fee | 17.09.2015 | Renewal fee patent year 03 | 17.09.2015 | Renewal fee patent year 04 | 17.09.2015 | Renewal fee patent year 05 | 17.09.2015 | Renewal fee patent year 06 | 17.09.2015 | Renewal fee patent year 07 | 17.09.2015 | Renewal fee patent year 08 | 17.09.2015 | Renewal fee patent year 09 | 17.09.2015 | Renewal fee patent year 10 | 17.09.2015 | Renewal fee patent year 11 | 10.03.2016 | Renewal fee patent year 12 | 10.03.2017 | Renewal fee patent year 13 | 13.03.2018 | Renewal fee patent year 14 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US2003108597 (CHANCELLOR MICHAEL B [US], et al) [Y] 1-15 * the whole document * * claims 1, 9, 12, 46-59 * * paragraph [0032] *; | [IAY]US2003113349 (COLEMAN WILLIAM P [US]) [I] 13-15 * the whole document * * paragraphs [0020] , [0 28] * * claims 1,20 * [A] 2 [Y] 1,3-15; | [A]US2003229034 (WAUGH JACOB [US], et al) [A] 1-15 * the whole document * * abstract * * claims 1,3,12,33 * * paragraphs [0052] - [0053] - [0 83] * * example 4 *; | [IAY]WO2004006954 (ALLERGAN INC [US], et al) [I] 13-15 * the whole document * * claims 1-35 * * page 16, paragraph 3 * [A] 2 [Y] 1,3-15; | [XPY]US2004220100 (WAUGH JACOB [US], et al) [XP] 1-15 * the whole document * * claims 1, 22, 68-71 * * paragraph [0136] * * example 8 * [Y] 1-15; | [A] - SCHANTZ E J ET AL, "PROPERTIES AND USE OF BOTULINUM TOXIN AND OTHER MICROBIAL NEUROTOXINS IN MEDICINE", MICROBIOLOGICAL REVIEWS, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, (19920301), vol. 56, no. 1, ISSN 0146-0749, pages 80 - 99, XP000569909 [A] 1-15 * the whole document * | [A] - YOKOYAMA T ET AL, "Botulinum toxin treatment of urethral and bladder dysfunction", ACTA MEDICA OKAYAMA, OKAYAMA, JP, (20021201), vol. 56, no. 6, ISSN 0386-300X, pages 271 - 277, XP002321124 [A] 1-15 * the whole document * |